Associate Professor, Medicine-Massachusetts General Hospital, Harvard Medical School
Oncology
Dr. Jennifer S. Temel, MD
|
|
Give Review
Jennifer Temel is an expert in the field of Oncology. He went to medical school at Washington University School of Medicine in St. Louis. He has 2 awards "Meaningful Use Stage 1 Certification" and "Super Doctor". Jennifer S. Temel is a published doctor and has 58 publications published. The lastest was: 'A Systematic Review of Adherence to Oral Antineoplastic Therapies.' Jennifer S. Temel, MD is registered with Medicare.
Publications
- Quality of life and mood predict posttraumatic stress disorder after hematopoietic stem cell transplantation.
- Nursing intervention to enhance outpatient chemotherapy symptom management: Patient-reported outcomes of a randomized controlled trial.
- A Randomized Controlled Trial of a CPR and Intubation Video Decision Support Tool for Hospitalized Patients.
- Quality of life and mood of patients and family caregivers during hospitalization for hematopoietic stem cell transplantation.
- The Integration of Early Palliative Care With Oncology Care: The Time Has Come for a New Tradition.
- Clinician roles in early integrated palliative care for patients with advanced Cancer: a qualitative study.
- Genotyping Lung Cancer Is an Investment in the Future.
- Dyspnea and Panic Among Patients With Newly Diagnosed Non-Small-Cell Lung Cancer.
- Perceptions of Health Status and Survival in Patients With Metastatic Lung Cancer.
- Observations in lung Cancer over multiple decades: an analysis of outcomes and cost at a single high-volume institution.
- Documentation of Oral Versus Intravenous Chemotherapy Plans in Patients With Metastatic Non-Small-Cell Lung Cancer.
- Early specialty palliative care--translating data in oncology into practice.
- Delivering High-Quality and Affordable Care Throughout the Cancer Care Continuum.
- Associations among prognostic understanding, quality of life, and mood in patients with advanced Cancer.
- Predicting life expectancy in patients with metastatic Cancer receiving palliative radiotherapy: The TEACHH model.
- The cultivation of prognostic awareness through the provision of early palliative care in the ambulatory setting: a communication guide.
- Early integration of palliative care services with standard oncology care for patients with advanced Cancer.
- End-of-Life Care Discussions in Patients With Advanced Cancer.
- Integrating palliative care: when and how?
- Predicting life expectancy in patients with advanced incurable Cancer: a review.
- Early palliative care in advanced lung Cancer: a qualitative study.
- Depression, survival, and epidermal growth factor receptor genotypes in patients with metastatic non-small cell lung Cancer.
- Electronic prompt to improve outpatient code status documentation for patients with advanced lung Cancer.
- Predictors of newly diagnosed Cancer patients' understanding of the goals of their care at initiation of chemotherapy.
- Early palliative care and metastatic non-small cell lung Cancer: Potential mechanisms of prolonged survival.
- Randomized Controlled Trial of a Video Decision Support Tool for Cardiopulmonary Resuscitation Decision Making in Advanced Cancer.
- Augmenting Communication and Decision Making in the Intensive Care Unit with a Cardiopulmonary Resuscitation Video Decision Support Tool: A TempOral Intervention Study.
- Integrating technology into palliative care research.
- A Phase I Study of Erlotinib and Hydroxychloroquine in Advanced Non-Small-Cell Lung Cancer.
- A Pilot Randomized Controlled Trial of Brief Cognitive-Behavioral Therapy for Anxiety in Patients with Terminal Cancer.
- Depression and survival in metastatic non-small-cell lung Cancer: effects of early palliative care.
- Effect of Early Palliative Care on Chemotherapy Use and End-of-Life Care in Patients With Metastatic Non-Small-Cell Lung Cancer.
- Clinical Cancer Advances 2011: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
- Tumor Epidermal Growth Factor Receptor Genotype and Depression in Stage IV Non-Small Cell Lung Cancer.
- Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung Cancer: results of a randomized study of early palliative care.
- Does palliative care improve outcomes for patients with incurable illness? A review of the evidence.
- Parsing Depression From Fatigue in Patients with Cancer Using the Fatigue Symptom Inventory.
- Phase II multicenter trial of voreloxin as second-line therapy in chemotherapy-sensitive or refractory small cell lung Cancer.
- Cetuximab monotherapy in patients with advanced non-small cell lung Cancer after prior epidermal growth factor receptor tyrosine kinase inhibitor therapy.
- Phase I/II study of AT-101 with topotecan in relapsed and refractory small cell lung Cancer.
- Early palliative care for patients with metastatic non-small-cell lung Cancer.
- Code status documentation in the outpatient electronic medical records of patients with metastatic Cancer.
- Use of video to facilitate end-of-life discussions with patients with Cancer: a randomized controlled trial.
- Phase 1-2a multicenter dose-ranging study of canfosfamide in combination with carboplatin and paclitaxel as first-line therapy for patients with advanced non-Small cel...
- Major depressive disorder in long-term Cancer survivors: analysis of the National Comorbidity Survey Replication.
- Epidermal growth factor receptor tyrosine kinase inhibitors and depression.
- A structured exercise program for patients with advanced non-small cell lung Cancer.
- A phase II study of oxaliplatin, pemetrexed, and bevacizumab in previously treated advanced non-small cell lung Cancer.
- Aggressiveness of care in a prospective cohort of patients with advanced NSCLC.
- Depression after diagnosis of advanced non-small cell lung Cancer and survival: a pilot study.
- A phase II study of gefitinib in patients with advanced thyroid Cancer.
- Phase II study: integrated palliative care in newly diagnosed advanced non-small-cell lung Cancer patients.
- Feasibility and validity of a one-item fatigue screen in a thoracic oncology clinic.
- Does initial staging or tumor histology better identify asymptomatic brain metastases in patients with non-small cell lung Cancer?
- Comprehensive symptom management in patients with advanced-stage non-small-cell lung Cancer.
- Community oncology in an era of payment reform.
- A Systematic Review of Adherence to Oral Antineoplastic Therapies.
Schools
Washington Center School of Medicine
Brigham and Women39s Hospital
Dana Farber
Procedures Preformed
- Thoracentesis
Conditions Treated
- Adrenal Gland Cancer
- Anemia
- Bladder Cancer
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- BlueConnect HMO
- Blue with Managed Care Behavioral Health HMO
- Preferred Blue PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- GHI PPO
- Fallon Community Health Plan
- Choice Care PPO
- Medical Mutual of Ohio
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Network Health
- Simplifi
- Tufts PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- Meaningful Use Stage 1 Certification
- Super Doctor
Education
-
Brigham and Women's Hospital -
Washington University School of Medicine in St. Louis
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1063496479 | |
| NPPES Provider LastName | TEMEL | |
| NPPES Provider FirstName | JENNIFER | |
| NPPES Provider ZIPCode | 02114 | |
| NPPES Provider State | MA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 36.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1063496479 |
| Last Name Of The Provider | TEMEL |
| First Name Of The Provider | JENNIFER |
| View All |
Similar Doctors
|
|
Dr. Benjamin L. Schlechter, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Suzanne T. Berlin, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Othon Iliopoulos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lawrence S. Blaszkowsky, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Kathy J. Selvaggi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael Hassett, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexi A. Wright, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jason Luke, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rachel A. Freedman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amy E. Fallon, MD
This Doctor is OpenDoctor Recommended.
|